Last edition
News about "Eyal Shamir"
IceCure Medical Study in PLOS One Highlights ProSense Cryoablation for Benign Breast Tumours
Independent Hungarian study shows ProSense cryoablation achieves up to 92.9 percent tumour reduction in fibroadenomas, supporting minimally invasive alternatives to surgery for benign breast lesions.
Eyal Shamir | 03/03/2026 | By News Bureau
IceCure Gets Regulatory Approval in Israel for XSense Cryoablation System
XSense is now approved in Israel for all indications for which ProSense has already received approval in Israel, including general surgery, dermatology neurology, including cryoanalgesia, thoracic surgery, ENT (Ear, Nose, Throat), gynaecology, oncology (including benign and malignant breast tumors), proctology and urology.
Eyal Shamir | 17/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy